Beryl Drugs reports standalone net profit of Rs 0.15 crore in the March 2025 quarter

Net profit of Beryl Drugs reported to Rs 0.15 crore in the quarter ended March 2025 as against net loss of Rs 0.35 crore during the previous quarter ended March 2024. Sales rose 33.22% to Rs 3.97 crore in the quarter ended March 2025 as against Rs 2.98 crore during the previous quarter ended March 2024.

For the full year,net profit declined 24.68% to Rs 0.58 crore in the year ended March 2025 as against Rs 0.77 crore during the previous year ended March 2024. Sales declined 20.88% to Rs 21.15 crore in the year ended March 2025 as against Rs 26.73 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	3.97	2.98	33	21.15	26.73	-21
OPM %	12.59	1.01	-	12.53	9.99	-
PBDT	0.42	-0.10	LP	2.12	2.21	-4
PBT	0.10	-0.42	LP	0.87	1.01	-14
NP	0.15	-0.35	LP	0.58	0.77	-25